Zacks Small Cap Research on MSN

TNXP: Secures commercial payer coverage for Tonmya® to provide access for ~35 million US patients

By David Bautz, PhD NASDAQ: TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonmyaâ„¢ Update Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is continuing the commercial launch of Tonmya® ...
Hosted on MSN

TNXP slips after hours on slower than expected launch for fibromyalgia drug

・Overall net revenue from sales in Q1 was $8.3 million, the company said. ・The company said that it now has funds to sustain itself till the second quarter of 2027. ・Total net revenue from sales of ...